Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)

SHE:301509 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	239.99	191.18	486.9	231.01	213.39	268.71
Trading Asset Securities	230.73	224.25	70.62	104.75	-	-
Cash & Short-Term Investments	470.72	415.43	557.52	335.76	213.39	268.71
Cash Growth	-23.27%	-25.49%	66.05%	57.34%	-20.59%	232.84%
Accounts Receivable	149.07	112.89	148.92	100.65	109.16	78.78
Other Receivables	0.42	0.4	16.03	64.24	13.72	42.04
Receivables	149.49	113.28	164.95	164.89	122.88	120.82
Inventory	175.03	194.97	216.88	231.92	178.17	131.96
Other Current Assets	784.54	780.2	917.96	19.67	15.52	7.86
Total Current Assets	1,580	1,504	1,857	752.25	529.96	529.35
Property, Plant & Equipment	354.44	363.05	391.89	388.05	306.15	228.53
Other Intangible Assets	46.58	47.13	48.55	49.82	48.85	9.58
Long-Term Deferred Tax Assets	16.71	18.68	8.8	9.2	5.35	5.38
Long-Term Deferred Charges	0.16	0.19	0.31	0.45	0.57	0.46
Other Long-Term Assets	315.84	330.46	3.77	10.23	6.63	4.56
Total Assets	2,313	2,263	2,311	1,210	897.51	777.87
Accounts Payable	45.72	38.83	45.02	82.26	54.98	33.57
Accrued Expenses	10.18	21.68	24.38	32.31	22.33	27.27
Short-Term Debt	-	-	5	24	30	48.65
Current Portion of Long-Term Debt	-	-	-	11.14	3.84	5.33
Current Portion of Leases	1.79	1.8	1.94	1.7	1.84	-
Current Income Taxes Payable	9.77	-	4.9	4.81	5.96	5.07
Current Unearned Revenue	4.97	8.8	11.24	14.3	9.38	7.09
Other Current Liabilities	24.04	21.47	28.39	93.53	16.61	103.69
Total Current Liabilities	96.47	92.57	120.87	264.06	144.94	230.67
Long-Term Debt	-	-	-	46.79	38.67	22.55
Long-Term Leases	2.83	2.96	4.71	4.43	1.12	-
Long-Term Unearned Revenue	8.54	9.01	6.8	7.88	3.77	4.39
Long-Term Deferred Tax Liabilities	8.87	10.03	7.26	8.02	5.13	3.55
Other Long-Term Liabilities	-	-	-	0.03	0.07	0.22
Total Liabilities	116.7	114.57	139.63	331.21	193.71	261.38
Common Stock	120.45	120.45	86.03	64.53	64.53	59.28
Additional Paid-In Capital	1,596	1,595	1,623	528.68	523.1	423.69
Retained Earnings	464.28	417.01	447.23	273.65	112.2	27.65
Comprehensive Income & Other	16.13	16.64	14.47	11.94	3.98	5.87
Shareholders' Equity	2,197	2,149	2,171	878.79	703.8	516.49
Total Liabilities & Equity	2,313	2,263	2,311	1,210	897.51	777.87
Total Debt	4.62	4.76	11.64	88.07	75.46	76.53
Net Cash (Debt)	466.1	410.67	545.88	247.69	137.93	192.18
Net Cash Growth	-23.26%	-24.77%	120.39%	79.58%	-28.23%	-
Net Cash Per Share	3.61	3.40	5.44	2.74	1.54	2.75
Filing Date Shares Outstanding	120.45	120.45	120.45	90.34	90.34	90.34
Total Common Shares Outstanding	120.45	120.45	120.45	90.34	90.34	90.34
Working Capital	1,483	1,411	1,736	488.19	385.02	298.68
Book Value Per Share	18.24	17.84	18.02	9.73	7.79	5.72
Tangible Book Value	2,150	2,102	2,122	828.97	654.95	506.91
Tangible Book Value Per Share	17.85	17.45	17.62	9.18	7.25	5.61
Land	-	1.37	1.35	1.33	1.21	1.24
Buildings	-	126.92	110.78	106.25	74.34	67.88
Machinery	-	526.85	518.12	485.98	337.86	257.75
Construction In Progress	-	76.82	70.61	41.44	94.84	67.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.